Discover K Pro
Make better pipeline decisions with Agentic AI
Challenges
- Scattered and fragmented data hinders confident decisions
- Stakeholders can’t query or stress-test data easily
- Small data-science teams and siloed workflows create bottlenecks and slow cross-team alignment
K Pro is the answer
- Unifies data into one decision-making tool, linking biology to clinical impact
- Natural-language queries unlock complex data instantly
- A shared intelligence layer breaks silos and speeds up decisions
One agentic tool that combines world class data and AI
Agentic Spaces
A community of biological reasoning agents
Analyze
- Explore multimodal patient biology
Explore biological hypotheses about drug mechanisms or patient populations directly from literature and multimodal patient data.
- Generate reports & data packages
Generate a static report summarizing key insights and underlying data for a query of interest.
- Generate and iterate hypotheses
Validate and test your hypotheses with smart scientific reasoning.
- Produce accurate publication ready visuals
Visualize and analyze complex data - slice and dice by variables for deeper insights.
- Conduct deep research
Deliver value by leveraging AI tools, agents and high-quality patient data in a single place, all while preserving data privacy.
Activate
- Hypothese from pre-clinical data
Explore biological hypotheses about drug mechanisms or patient populations directly from multimodal patient data.
- Optimize patient populations
Identify clinically-meaningful biomarkers to inform patient selection/stratification in clinical trials, powering actionable enrichment strategies and ideally refined inclusion/exclusion criteria.
Amplify
- Upload/interrogate your data
Safely update your own clinical data to determine predictive biomarkers, enrich your dataset or validate your clinical development strategies.
- Position your assets and set your business strategy
Analyze competitive landscape of clinical trials by indication/target to inform business opportunities.
- Enrich phase 1 data for decision making
Support early clinical trial decisions by contextualizing results with real-world multimodal twins, enriching insights through mechanistic analyses and addressing limited population size.
K Pro data
K Pro is powered by curated multimodal patient data
Expertly curated public data sets
- Access to 19 expertly curated and integrated public datasets and 25M articles
- Instant access to harmonized, analysis-ready data
- We spent 2,000 man days curating this data so you don’t have to
- Agents specifically trained to provide clear, coherent responses from specific literature
Expertly curated proprietry data from Owkin’s data network & MOSAIC
- Clean, AI-ready spatial multiomics data for 2200+ patients
- Six modalities per patient for robust, multi-dimensional insights
- Highly representative cohorts for high-unmet-need indications
- Structured for rapid, intelligent analysis
K Pro integrates with Owkin’s world-leading patient data network
Why K Pro?
Integrate multimodal data into analyses.
Flexible architecture to upload your data and incorporate your AI agents and tools.
Technical isolation and customer prompt, data and output segregation to protect IP.
Transparent train-of-thought reasoning, source citation, and statistical analysis.
Secure global cloud infrastructure via AWS, information secure through ISO 27001 compliance.
Flexible architecture to upload your data and incorporate your AI agents and tools.
Our most commonly asked questions
Yes, K Pro enables you to explore multimodal datasets from the Owkin patient data catalog and integrate them into your project according to your research needs. These datasets cover a range of modalities (bulk, single-cell, spatial transcriptomics, WES) as well as multiple therapeutic areas, including Oncology, Immunology & Inflammation, Cardiovascular, and Neurodegenerative diseases.
Strategic working sessions where Owkin goes in-house with pharma teams to explore how multimodal data and agentic AI can unlock new insights, break down translational research barriers and optimize clinical trials. The goal is to apply K-Pro to real-world challenges and rapidly uncover high-value opportunities.
Yes, your data can be integrated into the K Pro tool. To ensure data compatibility with K Pro, there are two options: clients can prepare datasets following our provided documentation, or our internal teams can handle the data preparation process. We utilize diverse pipelines, models, and expertise that the Owkin team has developed over the years to support various data modalities across multiple therapeutic areas. To maintain quality standards and data integrity, autonomous data uploads to K Pro are not currently available. However, we are actively developing this capability with a strong emphasis on data quality assurance and interoperability.
Agentic AI in pharma is rapidly moving from pilots to real-world impact, accelerating key steps such as data harmonization, hypothesis iteration and validation, biomarker discovery, and clinical trial optimization, all with strong guardrails and human oversight. At Owkin, this maturity is further advanced because our agents are grounded in high-quality multimodal data and deep biological context, enabling stronger grounding, clearer reasoning, and more trustworthy recommendations.
For each K Pro user, only the chat history is stored in the database, and it is always linked to that user and their organization. Access is restricted to the authenticated user alone. The database is a managed RDS instance within Owkin’s AWS account and can only be accessed by the backend service that requires it, through a secure service account and strict network policies.
Yes, your data can be integrated into the K Pro tool. To ensure data compatibility with K Pro, there are two options: clients can prepare datasets following our provided documentation, or our internal teams can handle the data preparation process. We utilize diverse pipelines, models, and expertise that the Owkin team has developed over the years to support various data modalities across multiple therapeutic areas. To maintain quality standards and data integrity, autonomous data uploads to K Pro are not currently available. However, we are actively developing this capability with a strong emphasis on data quality assurance and interoperability.
Yes, K Pro enables you to explore multimodal datasets from the Owkin patient data catalog and integrate them into your project according to your research needs. These datasets cover a range of modalities (bulk, single-cell, spatial transcriptomics, WES) as well as multiple therapeutic areas, including Oncology, Immunology & Inflammation, Cardiovascular, and Neurodegenerative diseases.
For each K Pro user, only the chat history is stored in the database, and it is always linked to that user and their organization. Access is restricted to the authenticated user alone. The database is a managed RDS instance within Owkin’s AWS account and can only be accessed by the backend service that requires it, through a secure service account and strict network policies.
Strategic working sessions where Owkin goes in-house with pharma teams to explore how multimodal data and agentic AI can unlock new insights, break down translational research barriers and optimize clinical trials. The goal is to apply K-Pro to real-world challenges and rapidly uncover high-value opportunities.
